🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

One Nucleus hosts its 25th Genesis conference in London on December 3. It will focus on the potential offered by innovation in life sciences to address global unmet medical needs, investment returns and new treatment development challenges. Register 👇 ow.ly/lIFS50WbrTW

Hayley French and Ray Boffey will be at ON Helix this Thursday. Catch up with them to find out about all the latest developments at #Domainex. They would be delighted to discuss how we can support your lead generation projects as your trusted partner. #ONHelix #DrugDiscovery

We’re partnering with SCI Ventures to use AI to uncover treatments for paralysis. Together, we aim to accelerate therapies for spinal cord injury and beyond. 🚀 Learn more: healx.ai/healx-and-sci-…

🚀 Year after year, attendance at BIO-Europe continues to grow because this is where critical business happens. On average companies achieve 20+ high-quality meetings with executive-level decision makers. ⏰ Book by July 25 to save €1,500 >> spr.ly/60164c2bC

👋We'd like to give a big welcome to everyone on Campus today for the One Nucleus ON Helix conference 'New Horizons for Bio Innovation'. If you haven't already, don't forget to download the conference app to keep track of proceedings. Have a great day! #ONHelix2025

Keep up to date with all the latest from PartitionBio x.com/PartitionBio/s…

Veteran cancer drug developer Dr Eric Martin has joined Storm Therapeutics as Chief Development Officer. His 20+ years' experience will be invaluable as the company advances its METTL3 inhibitor STC-15 through Phase 1b/2 development Full story 👇 ow.ly/7gM850WjBSO

We're proud to have worked with LifeArc to convene this Rare Disease task force and look forward to taking the important recommendations forward to #ChangeTheRareFuture for people living with rare conditions in the UK. Read the report - lifearc.org/rd-report/

#Domainex are attending Biotech’s Next Frontier: Harnessing Space to Achieve the Impossible on Earth” event, this afternoon at Babraham Research Campus. Make sure to catch up with Ray Boffey and Jesse Peterson if you are attending.

We like to think the Park offers much more than just lab and office space - it provides a thriving community for pioneering biotech, pharma, and tech companies. Find out more about life at the Park ow.ly/PfNs50Wkqzu #ResearchPark #Cambridge #Innovation #Wellbeing

📢Job opportunity Administrative Assistant CellCentric is looking for a dedicated self-starter who is keen to work within a dynamic team providing administrative support to ensure smooth daily operations. Full job description ow.ly/1POZ50Wneip

Join a UK Government-backed Trade Mission to #Japan this October (3–11 Oct 2025) and tap into one of the world’s fastest-growing #bioeconomy markets. ➡️ shorturl.at/yqXPP 🌏 This mission includes attendance at BioJapan / JTB Communication Design 2025, Asia’s largest

Have you seen PartitionBio's new website? It looks amazing and provides the chance to sign up for the latest information, partnership opportunities and early access to Partition's technology. Take a look 👇 ow.ly/854W50WngC5

.PhoreMost published a new study showcasing the capabilities of its high-throughput GlueSEEKER® platform to accelerate the design and development of novel molecular glue degraders. Read more ➡️shorturl.at/R9tbG

Academic Co-Founder & Chief Scientific Officer at Quotient Therapeutics Peter Campbell and Mestag Therapeutics's CEO Susan Hill are on the speaker line-up for BioCentury Grand Rounds Europe taking place in Cambridge. Find all the details👇 conferences.biocentury.com/grand-rounds-e… #BioCenturyGrandRounds

Are you looking for a new provider for your medicinal and synthetic chemistry? At #Domainex, we offer both standalone synthesis services alongside our fully integrated offering, allowing you to drive your projects forward.

Listen below for a snippet of a BBC interview with our CEO, Dr Sam Barrell CBE about the urgent need for people with rare diseases to have better access to effective treatments. You can read our joint report with Genetic Alliance UK here: lifearc.org/rd-report/

A collaboration between Park-based Broken String Biosciences and BioLizard will enable faster, more cost-effective development of gene edited therapies like CRISPR. Find out more about SafeGuide 👇 ow.ly/N21850Wr63t

⏰ It's the final day to save up to €1,500 on your BIO-Europe pass! Register now >> spr.ly/6013fzpvJ #BIOEurope #Partnering #Networking #IndustryInsights #Vienna

Are you ready to stand out in front of the industry's key decision makers? Apply for the Startup Spotlight at BIO-Europe today >> spr.ly/6017fzSfU